I agree that this site is using cookies. You can find further informations here.
X
Viney, Nicholas J.
25  results:
Articles (Online) X
Search for persons X
?
1

Switching from inotersen to eplontersen in patients with he..:

Conceição, Isabel ; Berk, John L. ; Weiler, Markus...
Journal of Neurology.  , 2024
Link: https://doi.org/10.1007/..
 
?
2

Evaluation of methodologies for indirect comparison of eplo..:

Karam, Chafic ; Gillmore, Julian ; Chen, Gengshi...
Neurology.  100 (2023)  17_supplement_2 - p. , 2023
Link: https://doi.org/10.1212/..
 
?
3

Characteristics of Patients with Hereditary Transthyretin A..:

Coelho, Teresa ; Waddington Cruz, Márcia ; Chao, Chi-Chao...
Neurology and Therapy.  12 (2022)  1 - p. 267-287 , 2022
Link: https://doi.org/10.1007/..
 
?
4

Population pharmacokinetic/pharmacodynamic modelling of epl..:

Diep, John K. ; Yu, Rosie Z. ; Viney, Nicholas J....
British Journal of Clinical Pharmacology.  88 (2022)  12 - p. 5389-5398 , 2022
Link: https://doi.org/10.1111/..
 
?
5

Prevalence and influence of LPA gene variants and isoform s..:

Karwatowska-Prokopczuk, Ewa ; Clouet-Foraison, Noemie ; Xia, Shuting...
Atherosclerosis.  324 (2021)  - p. 102-108 , 2021
Link: https://doi.org/10.1016/..
 
?
6

Design and Rationale of the Global Phase 3 NEURO-TTRansform..:

Coelho, Teresa ; Ando, Yukio ; Benson, Merrill D....
Neurology and Therapy.  10 (2021)  1 - p. 375-389 , 2021
Link: https://doi.org/10.1007/..
 
?
7

Rationale and Design of NEURO-TTRansform, a Phase 3 Study t..:

Khella, Sami ; Gertz, Morie A. ; Coelho, Teresa...
Neurology.  94 (2020)  15_supplement - p. , 2020
Link: https://doi.org/10.1212/..
 
?
8

Ligand conjugated antisense oligonucleotide for the treatme..:

Viney, Nicholas J. ; Guo, Shuling ; Tai, Li‐Jung...
ESC Heart Failure.  8 (2020)  1 - p. 652-661 , 2020
Link: https://doi.org/10.1002/..
 
?
9

Phase 1 Investigation of a Ligand-Conjugated Antisense Olig..:

Viney, Nicholas J. ; Tai, Li-Jung ; Jung, Shiangtung...
Journal of Cardiac Failure.  25 (2019)  8 - p. S80-S81 , 2019
Link: https://doi.org/10.1016/..
 
?
10

Potent reduction of plasma lipoprotein (a) with an antisens..:

Boffa, Michael B. ; Marar, Tanya T. ; Yeang, Calvin...
Journal of Lipid Research.  60 (2019)  12 - p. 2082-2089 , 2019
Link: https://doi.org/10.1194/..
 
?
11

Temporal variability in lipoprotein(a) levels in patients e..:

Marcovina, Santica M. ; Viney, Nicholas J. ; Hughes, Steven G....
Journal of Clinical Lipidology.  12 (2018)  1 - p. 122-129.e2 , 2018
Link: https://doi.org/10.1016/..
 
?
12

Relationship of lipoprotein(a) molar concentrations and mas..:

Tsimikas, Sotirios ; Fazio, Sergio ; Viney, Nicholas J....
Journal of Clinical Lipidology.  12 (2018)  5 - p. 1313-1323 , 2018
Link: https://doi.org/10.1016/..
 
?
13

Relationship between "LDL-C", estimated true LDL-C, apolipo..:

Viney, Nicholas J. ; Yeang, Calvin ; Yang, Xiaohong...
Journal of Clinical Lipidology.  12 (2018)  3 - p. 702-710 , 2018
Link: https://doi.org/10.1016/..
 
?
14

TUXEDO: a phase I/II trial of cetuximab with chemoradiother..:

James, Nicholas D. ; Liu, Wenyu ; Pirrie, Sarah...
BJU International.  131 (2022)  1 - p. 63-72 , 2022
Link: https://doi.org/10.1111/..
 
?
15

Internal checkpoint regulates T cell neoantigen reactivity ..:

Palmer, Douglas C. ; Webber, Beau R. ; Patel, Yogin...
Med.  3 (2022)  10 - p. 682-704.e8 , 2022
Link: https://doi.org/10.1016/..
 
1-15